Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy vs Chemoradiotherapy in Locally Advanced HNSCC
NCT03815903Phase 3Recruiting
- Sponsor
- Hospital de Amor
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, paclitaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by Hospital de Amor. Started Dec 2018; status: recruiting.
02
Drugs
cisplatinpaclitaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03815903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03815903.